JP2007520565A5 - - Google Patents

Download PDF

Info

Publication number
JP2007520565A5
JP2007520565A5 JP2006552282A JP2006552282A JP2007520565A5 JP 2007520565 A5 JP2007520565 A5 JP 2007520565A5 JP 2006552282 A JP2006552282 A JP 2006552282A JP 2006552282 A JP2006552282 A JP 2006552282A JP 2007520565 A5 JP2007520565 A5 JP 2007520565A5
Authority
JP
Japan
Prior art keywords
animal
human
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006552282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007520565A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/003636 external-priority patent/WO2005077940A1/en
Publication of JP2007520565A publication Critical patent/JP2007520565A/ja
Publication of JP2007520565A5 publication Critical patent/JP2007520565A5/ja
Pending legal-status Critical Current

Links

JP2006552282A 2004-02-04 2005-02-04 デヒドロフェニラヒスチン及びそれらの類似体、並びにデヒドロフェニラヒスチン及びそれらの類似体の合成 Pending JP2007520565A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54207304P 2004-02-04 2004-02-04
US62426204P 2004-11-01 2004-11-01
PCT/US2005/003636 WO2005077940A1 (en) 2004-02-04 2005-02-04 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof

Publications (2)

Publication Number Publication Date
JP2007520565A JP2007520565A (ja) 2007-07-26
JP2007520565A5 true JP2007520565A5 (enrdf_load_stackoverflow) 2008-04-03

Family

ID=34864489

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006552282A Pending JP2007520565A (ja) 2004-02-04 2005-02-04 デヒドロフェニラヒスチン及びそれらの類似体、並びにデヒドロフェニラヒスチン及びそれらの類似体の合成

Country Status (9)

Country Link
EP (1) EP1711487A1 (enrdf_load_stackoverflow)
JP (1) JP2007520565A (enrdf_load_stackoverflow)
KR (1) KR101228104B1 (enrdf_load_stackoverflow)
AU (1) AU2005212399B2 (enrdf_load_stackoverflow)
BR (1) BRPI0506655A (enrdf_load_stackoverflow)
CA (1) CA2553630A1 (enrdf_load_stackoverflow)
IL (1) IL176932A0 (enrdf_load_stackoverflow)
NZ (1) NZ548659A (enrdf_load_stackoverflow)
WO (1) WO2005077940A1 (enrdf_load_stackoverflow)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004054498A2 (en) 2002-08-02 2004-07-01 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
WO2007035841A1 (en) * 2005-09-21 2007-03-29 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
WO2015051543A1 (en) 2013-10-11 2015-04-16 Dalian Wanchun Biotechnology Co., Ltd. Cancer treatment with combination of plinabulin and taxane
CA2975729A1 (en) * 2015-02-12 2016-08-18 Beyondspring Pharmaceuticals, Inc. Use of plinabulin in combination with immune checkpoint inhibitors
JP6904570B2 (ja) * 2015-03-06 2021-07-21 ビヨンドスプリング ファーマシューティカルズ,インコーポレイテッド 脳腫瘍の治療方法
RU2736045C2 (ru) 2015-03-06 2020-11-11 Бейондспринг Фармасьютикалс, Инк. Способ лечения рака, ассоциированного с мутацией ras
CA2991059C (en) 2015-07-13 2024-01-16 Beyondspring Pharmaceuticals, Inc. Plinabulin monohydrate polymorphs
WO2017139231A1 (en) 2016-02-08 2017-08-17 Beyondspring Pharmaceuticals, Inc. Compositions containing tucaresol or its analogs
KR20190015361A (ko) 2016-06-06 2019-02-13 비욘드스프링 파마수티컬스, 인코포레이티드. 호중구감소증을 줄이는 조성물 및 방법
US10851086B2 (en) 2016-08-12 2020-12-01 Marine Biomedical Research Institute Of Qingdao Co., Ltd. Polycrystalline form of dehydrophenylahistin-like compound, and manufacturing and purification method and application thereof
WO2018129381A1 (en) 2017-01-06 2018-07-12 Beyondspring Pharmaceuticals, Inc. Tubulin binding compounds and therapeutic use thereof
AU2018217120B2 (en) 2017-02-01 2024-02-08 Beyondspring Pharmaceuticals, Inc. Method of reducing neutropenia
EP3595653B1 (en) * 2017-03-13 2023-03-08 Beyondspring Pharmaceuticals, Inc. Compositions of plinabulin and use thereof
CN112135614A (zh) 2018-01-24 2020-12-25 大连万春布林医药有限公司 通过施用普那布林减少血小板减少症的组合物和方法
CN108524442B (zh) * 2018-06-05 2022-01-28 深圳海王医药科技研究院有限公司 一种抗肿瘤药物的注射剂及其制备方法
JP2018199726A (ja) * 2018-09-26 2018-12-20 ビヨンドスプリング インコーポレイテッド プリナブリン及びタキサンの組合せがん治療
JP2024513505A (ja) 2021-04-09 2024-03-25 ビヨンドスプリング ファーマシューティカルズ,インコーポレイテッド 腫瘍を治療するための組成物及び方法
CN118369101A (zh) * 2021-10-07 2024-07-19 大连万春布林医药有限公司 治疗癌症和肿瘤的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318789C2 (de) * 1983-05-24 1987-04-02 Eduard Gerlach GmbH Chemische Fabrik, 4990 Lübbecke Deodorant
GB9402807D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
US6069146A (en) * 1998-03-25 2000-05-30 The Regents Of The University Of California Halimide, a cytotoxic marine natural product, and derivatives thereof
US6358957B1 (en) * 1998-11-12 2002-03-19 Nereus Pharmaceuticals, Inc. Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
NZ519989A (en) * 2000-01-18 2004-05-28 Nereus Pharmaceuticals Inc Cell division inhibitors and process for producing the same
WO2001095858A2 (en) * 2000-05-09 2001-12-20 Adpharma, Inc. Piperazinedione compounds
WO2004054498A2 (en) * 2002-08-02 2004-07-01 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof

Similar Documents

Publication Publication Date Title
JP2007520565A5 (enrdf_load_stackoverflow)
JP2006503588A5 (enrdf_load_stackoverflow)
JP2009524695A5 (enrdf_load_stackoverflow)
JP2003503454A5 (enrdf_load_stackoverflow)
JP2010525055A5 (enrdf_load_stackoverflow)
ATA11842004A (de) Impfstoff gegen die alzheimer-krankheit
JP2005524670A5 (enrdf_load_stackoverflow)
JP2009504909A5 (enrdf_load_stackoverflow)
JP2008542528A5 (enrdf_load_stackoverflow)
JP2008519810A5 (enrdf_load_stackoverflow)
JP2009532412A5 (enrdf_load_stackoverflow)
JP2008513426A5 (enrdf_load_stackoverflow)
JP2008517002A5 (enrdf_load_stackoverflow)
JP2008513427A5 (enrdf_load_stackoverflow)
RU2003110288A (ru) Вещество, обладающее антидепрессивной активностью
IL186851A0 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
JP2009509934A5 (enrdf_load_stackoverflow)
JP2007508806A5 (enrdf_load_stackoverflow)
JP2006522596A5 (enrdf_load_stackoverflow)
JP2006505577A5 (enrdf_load_stackoverflow)
JP2005531640A5 (enrdf_load_stackoverflow)
DE602006018617D1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivaten
JP2008143899A5 (enrdf_load_stackoverflow)
RU2005128615A (ru) Средство для лечения заболеваний пародонта
JP2005298393A5 (enrdf_load_stackoverflow)